by John Conrad | Sep 26, 2025 | Policy News
John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization (iBIO) issued the following response regarding proposed 100% import duties on proprietary pharmaceutical products: “iBIO supports expanding domestic life sciences manufacturing....
